ARCHIVES

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | March 20, 2009

Download PDF Visit The Full Archive

Related Articles

Genentech’s Ferrara Wins Lasker Award For VEGF Discovery

October 8, 2010

Zerhouni to Cancer Researchers: “Stay Calm, Cool” About Funding- And Beware of Myths.

June 16, 2006

NCI Treatment Division To Recompete $10 Million In Resource Contracts; Board Okays New Projects

November 12, 1976

University Fires Bezwoda For Scientific Misconduct.

March 17, 2000

In Brief: NCA to Hear Reports On Outstanding Investigator Awards, Defining QRA, P01 Guidelines, Gallow Work

May 6, 1983

Sharfstein To Leave FDA

January 7, 2011